SEARCH

SEARCH BY CITATION

References

  • Achanta, G., Pelicano, H., Feng, L., Plunkett, W. & Huang, P. (2001) Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Research, 61, 87238729.
  • Alas, S., Ng, C.P. & Bonavida, B. (2002) Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma. Clinical Cancer Research, 8, 836845.
  • D'Amours, D., Desnoyers, S., D'Silva, I. & Poirier, G. (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochemistry Journal, 342, 249268.
  • Banasik, M., Komura, H., Shimoyama, M. & Ueda, K. (1992) Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl) transferase. Journal of Biological Chemistry, 267, 15691575.
  • Begleiter, A., Glazer, R.I., Israels, L.G., Pugh, L. & Johnston, J.B. (1987) Induction of DNA strand breaks in chronic lymphocytic leukaemia following treatment with 2′-deoxycoformycin in vivo and in vitro. Cancer Research, 47, 24982503.
  • Begleiter, A., Pugh, L., Israels, L.G. & Johnston, J.B. (1988) Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2′-deoxycoformycin and deoxyadenosine in vitro. Cancer Research, 48, 39813986.
  • Beham, A., Marin, M.C., Fernandez, A., Herrmann, J., Brisbay, S., Tari, A.M., Lopez-Berestein, G., Lozano, G., Sarkiss, M. & McDonnell, T.J. (1997) Bcl-2 inhibits p53 nuclear import following DNA damage. Oncogene, 15, 27672772.
  • Bellosillo, B., Dalmau, M., Colomer, D. & Gil, J. (1997) Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood, 89, 33783384.
  • Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E. & Gil, J. (1999) In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood, 94, 28362843.
  • Beutler, E., Carson, D., McMillan, R. & Longmire, R. (1997) Development of 2-Chlorodeoxyadenosine (2-Cda) as a chemotherapeutic and immunosuppressive drug. In: Nucleoside analogs in cancer therapy (ed. by B.D.Cheson, M.J.Keating & W.Plunkett), pp. 159174. Marcel Dekker, New York.
  • Boerrigter, M. (1991) DNA strand breaks in human lymphocytes: a reevaluation. Experimental Cell Research, 196, 15.
  • Brox, L., Ng, A., Pollock, E. & Belch, A. (1984) DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Research, 44, 934937.
  • Caligaris-Cappio, F. (2000) Biology of chronic lymphocytic leukemia. Review of Clinical Experimental Hematology, 4, 521.
  • Carrera, C.J., Saven, A. & Piro, L.D. (1994) Purine metabolism of lymphocytes. New Drug Therapy, 8, 357382.
  • Carson, D.A., Kaye, J. & Seegmiller, J.E. (1977) Lymphospecific toxicity in adenosine deaminase deficiency: possible role of nucleoside kinase(s). Proceedings of the National Academy of Sciences of the United States of America, 74, 56775681.
  • Carson, D.A., Carrera, C.J., Wasson, D.B. & Yamanaka, H. (1988) Programmed cell death and adenine nucleotide metabolism in human lymphocytes. Advances in Enzyme Regulation, 27, 395404.
  • Chandra, J., Gilbreath, J., Freireich, E.J., Kliche, K.O., Andreeff, M., Keating, M. & McConkey, D.J. (1997) Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood, 90, 36733681.
  • Cheson, B.D. & Grever, M.R. (1997) Clinical development of 2′-Deoxycoformycin. In: Nucleoside analogs in cancer therapy (ed. by B.D.Cheson, M.J.Keating & W.Plunkett), pp. 95112. Marcel Dekker, New York.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • DeMurcia, G. & Menissier-deMurcia, J.M. (1994) Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends in Biochemistry and Science, 19, 172176.
  • Dohner, H., Fischer, C., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogues in chronic B-cell leukaemias. Blood, 85, 15801589.
  • Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 19101916.
  • Eastman, A. & Barry, M.A. (1992) The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Investigations, 10, 229240.
  • Eguchi, Y., Shimizu, S. & Tsujimoto, Y. (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Research, 57, 18351840.
  • El Rouby, S., Thomas, A., Costin, D., Rosenberg, C.R., Potmesil, M., Silber, R. & Newcombe, E.W. (1993) p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 82, 34523459.
  • Feng, L., Achanta, G., Pelicano, H., Zhang, W., Plunkett, W. & Huang, P. (2000) Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage. International Journal of Molecular Medicine, 5, 597604.
  • De La Fuente, M.T., Casanova, B., Moyano, J.V., Garcia-Gila, M., Sanz, L., Garcia-Marco, J., Silva, A. & Garcia-Pardo, A. (2002) Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. Journal of Leukemia Biology, 71, 495502.
  • Galmarini, C.M., Mackey, J.R. & Dumontet, C. (2001) Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia, 15, 875890.
  • Gandhi, V. & Plunkett, W. (2002) Cellular and clinical pharmacology of fludarabine. Clinical Pharmacokinetics, 41, 93103.
  • Ganeshaguru, K., Ho, A.D., Piga, A., Catovsky, D. & Hoffbrand, A.V. (1987) Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias. Leukemia Research, 11, 941945.
  • Gartenhaus, R.B., Wang, P., Hoffman, M., Janson, D. & Rai, K.R. (1996) The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukaemia cells treated with 2-chlorodeoxyadenosine. Journal of Molecular Medicine, 74, 143147.
  • Genini, D., Adachi, S., Rose, D.W., Carrera, C.J., Cottam, H.B., Carson, D.A. & Leoni, L.M. (2000a) Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukaemia cells by damaging the DNA and by directly affecting the mitochondria. Blood, 96, 35373543.
  • Genini, D., Budihardjo, I., Plunkett, W., Wang, X., Carrera, C.J., Cottam, H.B., Carson, D.A. & Leoni, L.M. (2000b) Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. Journal of Biological Chemistry, 275, 2934.
  • Greer, W.L. & Kaplan, J.G. (1984) Regulation of repair of naturally occurring DNA strand breaks in lymphocytes. Biochemistry and Biophysics Research Communications, 122, 366372.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 18481854.
  • Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J.C. (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 18201828.
  • Hanauske, A.-R. & Von Hoff, D.D. (1997) Clinical development of fludarabine. In: Nucleoside analogs in cancer therapy (ed. by B.D.Cheson, M.J.Keating & W.Plunkett), pp. 113158. Marcel Dekker, New York.
  • Hirsch, T., Marchetti, P., Susin, S.A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M. & Kroemer, G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene, 15, 15731581.
  • Ho, A.D., Ganeshaguru, K., Knauf, W.U., Dietz, G., Trede, I., Hunstein, W. & Hoffbrand, A.V. (1988) Clinical response to deoxycoformcin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo. Blood, 72, 18841890.
  • Hoshino, J., Beckman, G. & Kroger, H. (1993) 3-aminobenzamide protects the mouse thymocytes in vitro from dexamethasone-mediated apoptotic cell death and cytolysis without changing DNA strand breakage. Journal of Steroid Biochemistry and Molecular Biology, 44, 113119.
  • Huang, P. & Plunkett, W. (1995) Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemotherapy and Pharmacology, 36, 181188.
  • Huang, P., Sandoval, A., Van Den Neste, E., Keating, M.J. & Plunkett, W. (2000) Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine. Leukemia, 14, 14051413.
  • Hupp, T.R., Lane, D.P. & Ball, K.L. (2000) Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochemistry Journal, 352, 117.
  • Johnston, J.B., Daeninck, P., Verburg, L., Lee, K., Williams, G., Israels, L.G., Mowat, M.R. & Begleiter, A. (1997) p53, MDM2, BAX, BCL-2 and drug resistance in chronic lymphocytic leukemia. Leukemia Lymphoma, 26, 435449.
  • Johnstone, A.P. (1984) Rejoining of DNA strand breaks is an early nuclear event during the stimulation of quiescent lymphocytes. European Journal of Biochemistry, 140, 401406.
  • Jostes, R., Reese, J.A., Cleaver, J.E., Molero, M. & Morgen, W.F. (1989) Quiescent human lymphocytes do not contain DNA strand breaks detectable by alkaline elution. Experimental Cell Research, 182, 513520.
  • Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E. & Poirier, G.G. (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Research, 53, 39763985.
  • Kawasaki, H., Carrera, C.J., Piro, L.D., Saven, A., Kipps, T.J. & Carson, D.A. (1993) Relationship of deoxycyidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood, 81, 597601.
  • Keating, M.J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E.J. & McCredie, K.B. (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood, 74, 1925.
  • Keating, M.J., O'Brien, S. & Albitar, M. (2002) Emerging information on the use of rituximab in chronic lymphocytic leukemia. Seminars in Oncology, 29, 7074.
  • Kefford, R.F. & Fox, R.M. (1982) Purine deoxynucleoside toxicity in non-dividing human lymphoid cells. Cancer Research, 42, 324330.
  • Kennedy, B., Rawstron, A., Carter, C., Ryan, M., Speed, K., Lucas, G. & Hillmen, P. (2002) Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia. Blood, 99, 22452247.
  • Kipps, T.J. (2000) Chronic lymphocytic leukemia. Current Opinions in Hematology, 7, 223234.
  • Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H.G., Zhang, X., Bullrich, F., Croce, C.M., Rai, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 33793389.
  • Kitada, S., Zapata, J.M., Andreeff, M. & Reed, J.C. (1999) Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 106, 9951004.
  • Klein, U., Tu, Y., Stolovitzky, G.A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. & Dalla-Favera, R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Journal of Experimental Medicine, 194, 16251638.
  • Kuwabara, M., Tanabe, K., Hiraoka, W., Tamura, Y., Sato, F., Matsuda, A. & Ueda, T. (1991) 2-Chlorodeoxyadenosine inhibits the repair of DNA double-strand breaks and does not inhibit the repair of DNA single-strand breaks in X-irradiated Chinese hamster V79 cells. Chemical and Biological Interactions, 79, 349358.
  • Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 1516.
  • Leist, M. & Nicotera, P. (1997) The shape of cell death. Biochemistry and Biophysics Research Communications, 236, 19.
  • Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323331.
  • Lin, K., Sherrington, P.D., Dennis, M., Matrai, Z., Cawley, J.C. & Pettitt, A.R. (2002) Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood, 100, 14041409.
  • Matsumoto, S.S., Yu, A.L. & Yu, J. (1985) Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin. Cancer Investigations, 3, 225233.
  • O'Brien, S.M., Kantarjian, H.M., Cortes, J., Beran, M., Koller, C.A., Giles, F.J., Lerner, S. & Keating, M. (2001) Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. Journal of Clinical Oncology, 19, 14141420.
  • Osterborg, A., Dyer, M.J., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D. & Mellstedt, H. (1997) Phase II multicenter Study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of Campath-1H Treatment in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology, 15, 15671574.
  • Pepper, C., Thomas, A., Hidalgo de Quintana, J., Davies, S., Hoy, T. & Bentley, P. (1999a) Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia: the role of Bcl-2 family dysregulation. Leukemia Research, 23, 10071014.
  • Pepper, C., Thomas, A., Hoy, T., Cotter, F. & Bentley, P. (1999b) Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 107, 611615.
  • Pepper, C., Hooper, K., Thomas, A., Hoy, T. & Bentley, P. (2001) Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells. Leukemia Lymphoma, 42, 491498.
  • Pettitt, A.R. & Cawley, J.C. (2000) Caspases influence the mode but not the extent of cell death induced by purine analogues in chronic lymphocytic leukaemia. British Journal of Haematology, 109, 800804.
  • Pettitt, A.R., Sherrington, P.D. & Cawley, J.C. (1999a) The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia. British Journal of Haematology, 106, 10491051.
  • Pettitt, A.R., Clarke, A.R., Cawley, J.C. & Griffiths, S.D. (1999b) Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms. British Journal of Haematology, 105, 986988.
  • Pettitt, A.R., Sherrington, P.D. & Cawley, J.C. (2000) Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Cancer Research, 60, 41874193.
  • Pettitt, A.R., Stankovic, T., Sherrington, P.D., Stewart, G., Cawley, J.C. & Taylor, A.M.R. (2001) p53 dysfunction in B-cell chronic lymphocytic leukaemia: inactivation of ATM as an alternative to TP53 mutation. Blood, 98, 814822.
  • Plunkett, W. & Gandhi, V. (1997) Nucleoside analogs: cellular pharmacology, mechanism of action, and strategies for combination therapy. In: Nucleoside analogs in cancer therapy (ed. by B.D.Cheson, M.J.Keating & W.Plunkett), pp. 136. Marcel Dekker, New York.
  • Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D. & Schiffer, C.A. (2000) Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New England Journal of Medicine, 14, 17501757.
  • Rankin, P.W., Jacobson, E.L., Benjamin, R.C., Moss, J. & Jacobson, M.K. (1989) Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. Journal of Biological Chemistry, 15, 43124317.
  • Robertson, L.E., Chubb, S., Meyn, R.E., Story, M., Ford, R., Hittelman, W.N. & Plunkett, W. (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-d-arabinosyl-2-fluoroadenine. Blood, 81, 143150.
  • Romano, M.F., Lamberti, A., Tassone, P., Alfinito, F., Costantini, S., Chiurazzi, F., Defrance, T., Bonelli, P., Tuccillo, F., Turco, M.C. & Venuta, S. (1998) Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood, 1, 990995.
  • Romano, M.F., Lamberti, A., Turco, M.C. & Venuta, S. (2000) CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis. Leukemia and Lymphoma, 36, 255262.
  • Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, X., Yang, L., Pickeral, O.K., Rassenti, L.Z., Powell, J., Botstein, D., Byrd, J.C., Grever, M.R., Cheson, B.D., Chiorazzi, N., Wilson, W.H., Kipps, T.J., Brown, P.O. & Staudt, L.M. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 194, 16391647.
  • Sabbatini, P., Chiou, S.K., Rao, L. & White, E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Molecular Cell Biology, 15, 10601070.
  • Sampath, D. & Plunkett, W. (2000) The role of C-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage. Cancer Research, 60, 64086415.
  • Sandoval, A., Consoli, U. & Plunkett, W. (1996) Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clinical Cancer Research, 2, 17311741.
  • Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B. & Carson, D.A. (1985) Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. Journal of Clinical Investigations, 75, 377383.
  • Shen, Y. & Shenk, T. (1994) Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proceedings of the National Academy of Sciences of the United States of America, 91, 89408944.
  • Skidmore, C.J., Davies, M.I., Goodwin, P.M., Halldorsson, H., Lewis, P., Shall, S. & Zia'ee, A.-A. (1979) The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma radiation and N-methyl-N-nitrosourea. European Journal of Biochemistry, 101, 135142.
  • Summerfield, G.P., Taylor, P.R., Mounter, P.J. & Proctor, S.J. (2002) High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma. British Journal of Haematology, 116, 781786.
  • Szondy, Z. (1995) The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine. Biochemistry Journal, 311, 585588.
  • Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. & Newcombe, E. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 10551062.
  • Thornberry, N.A. & Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 13121316.
  • Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, E., Morel, P. & Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 31483157.
  • Wyllie, A.H. (1998) An endonuclease at last. Nature, 391, 2021.
  • Yamauchi, T., Nowak, B.J., Keating, M.J. & Plunkett, W. (2001) DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clinical Cancer Research, 7, 35803589.
  • Zamzami, N. & Kroemer, G. (2001) The mitochondrion in apoptosis: how Pandora's box opens. National Review of Molecular Cell Biology, 2, 6771.
  • Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B. & Kroemer, G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. Journal of Experimental Medicine, 182, 367377.